Patent Assignment
Reel/Frame 014714/0465
Assignment of Assignor's Interest
Recorded: 2004-06-09
Pages: 5
Assignor
EPIGENESIS PHARMACEUTICALS, INC.
Executed: 2004-05-18
Assignee
EPIGENESIS PHARMACEUTICALS LLC
7 CLARKE DRIVE, CRANBURY, NEW JERSEY, 08512
Covered Properties
(23)
Nebulizer Formulations of Dehydroepiandrosterone and Methods of Treating Asthma or Chronic Obstructive Pulmonary Disease Using Compositions Thereof
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a methylxanthine derivative for treatment of asthma or chronic obstructive pulmonary disease
Application:
10/698,064 →
Publication:
US 2005/0026848
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease
Application:
10/698,066 →
Publication:
US 2005/0026890
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or VCAM inhibitor for treatment of asthma or chronic obstructive pulmonary disease
Application:
10/698,071 →
Publication:
US 2005/0026879
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a cromone for treatment of asthma or chronic obstructive pulmonary disease
Application:
10/698,072 →
Publication:
US 2005/0026880
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-IgE antibody for treatment of asthma or chronic obstructive pulmonary disease
Application:
10/698,073 →
Publication:
US 2005/0026881
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
Application:
10/698,076 →
Publication:
US 2005/0026882
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
Application:
10/698,077 →
Publication:
US 2005/0026883
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
Application:
10/698,078 →
Publication:
US 2005/0026884
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
Application:
10/698,079 →
Publication:
US 2005/0038004
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a lipoxygenase inhibitor for treatment of asthma or chronic obstructive pulmonary disease
Application:
10/698,080 →
Publication:
US 2005/0043282
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a glucocorticosteroid for treatment of asthma, chronic obstructive pulmonary disease or allergic rhinitis
Application:
10/815,576 →
Publication:
US 2005/0222049
Powder dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof
Application:
60/477,987 →
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
Application:
60/492,226 →
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease
Application:
60/492,227 →
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a lipoxygenase inhibitor for treatment of asthma or chronic obstructive pulmonary disease
Application:
60/492,228 →
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
Application:
60/492,229 →
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-muscarinic agent for treatment of asthma or chronic obstructive pulmonary
Application:
60/492,230 →
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-IgE antibody for treatment of asthma or chronic obstructive pulmonary disease
Application:
60/492,231 →
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
Application:
60/492,232 →
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
Application:
60/492,233 →
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or VCAM inhibitor for treatment of asthma or chronic obstructive pulmonary disease
Application:
60/492,263 →
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a methylxanthine derivative for treatment of asthma or chronic obstructive pulmonary disease
Application:
60/492,264 →
Related Assignments
(22)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 22, 2003
From: LEONARD, SHERRY A.; JOHNSON, KEITH A.
To: EPIGENESIS PHARMACEUTICALS, INC.
Reel/Frame 014533/0744 →
Assignment of Assignor's Interest
Dec 11, 2003
From: ROBINSON, CYNTHIA B.; BALL, HOWARD A.
To: EPIGENESIS PHARMACEUTICALS, INC.
Reel/Frame 014799/0086 →
Assignment of Assignor's Interest
Dec 11, 2003
From: ROBINSON, CYNTHIA B.; BALL, HOWARD A.
To: EPIGENESIS PHARMACEUTICALS, INC.
Reel/Frame 014801/0014 →
Assignment of Assignor's Interest
Dec 11, 2003
From: ROBINSON, CYNTHIA B.; BALL, HOWARD A.
To: EPIGENESIS PHARMACEUTICALS, INC.
Reel/Frame 014799/0265 →
Assignment of Assignor's Interest
Dec 11, 2003
From: ROBINSON, CYNTHIA B.; BALL, HOWARD A.
To: EPIGENESIS PHARMACEUTICALS, INC.
Reel/Frame 014799/0900 →
Assignment of Assignor's Interest
Dec 11, 2003
From: ROBINSON, CYNTHIA B.; BALL, HOWARD A.
To: EPIGENESIS PHARMACEUTICALS, INC.
Reel/Frame 014799/0947 →
Assignment of Assignor's Interest
Dec 11, 2003
From: ROBINSON, CYNTHIA B.; BALL, HOWARD A.
To: EPIGENESIS PHARMACEUTICALS, INC.
Reel/Frame 014799/0250 →
Assignment of Assignor's Interest
Feb 11, 2004
From: ROBINSON, CYNTHIA B.; BALL, HOWARD A.
To: EPIGENESIS PHARMACEUTICALS, INC.
Reel/Frame 014982/0314 →
Assignment of Assignor's Interest
Feb 11, 2004
From: ROBINSON, CYNTHIA B.; BALL, HOWARD A.
To: EPIGENESIS PHARMACEUTICALS, INC.
Reel/Frame 014982/0427 →
Assignment of Assignor's Interest
Feb 11, 2004
From: ROBINSON, CYNTHIA R.; BALL, HOWARD A.
To: EPIGENSIS PHARMACEUTICALS, INC.
Reel/Frame 014983/0899 →
Assignment of Assignor's Interest
Feb 11, 2004
From: ROBINSON, CYNTHIA B.; BALL, HOWARD A.
To: EPIGENESIS PHARMACEUTICALS, INC.
Reel/Frame 014982/0946 →
Assignment of Assignor's Interest
Feb 11, 2004
From: ROBINSON, CYNTHIA B.; BALL, HOWARD A.
To: EPIGENESIS PHARMACEUTICALS, INC.
Reel/Frame 014983/0988 →
Assignment of Assignor's Interest
Feb 11, 2004
From: ROBINSON, CYNTHIA B.; BALL, HOWARD A.
To: EPIGENESIS PHARMACEUTICALS, INC.
Reel/Frame 014983/0909 →
Assignment of Assignor's Interest
Feb 11, 2004
From: ROBINSON, CYNTHIA B.; BALL, HOWARD A.
To: EPIGENESIS PHARMACEUTICALS, INC.
Reel/Frame 014983/0904 →
Assignment of Assignor's Interest
Feb 11, 2004
From: ROBINSON, CYNTHIA B.; BALL, HOWARD A.
To: EPIGENESIS PHARMACEUTICALS, INC.
Reel/Frame 014967/0956 →
Assignment of Assignor's Interest
Feb 11, 2004
From: ROBINSON, CYNTHIA B.; BALL, HOWARD A.
To: EPIGENESIS PHARMACEUTICALS, INC.
Reel/Frame 014982/0274 →
Assignment of Assignor's Interest
Feb 11, 2004
From: ROBINSON, CYNTHIA B.; BALL, HOWARD A.
To: EPIGENESIS PHARMACEUTICALS, INC.
Reel/Frame 014982/0279 →
Assignment of Assignor's Interest
Mar 31, 2004
From: ROBINSON, CYNTHIA B.; BALL, HOWARD A.
To: EPIGENESIS PHARMACEUTICALS, INC.
Reel/Frame 015178/0716 →
First Lien Patent Security Agreement
Mar 21, 2011
From: GLOBAL TEL*LINK CORPORATION; DSI-ITI, LLC
To: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
Reel/Frame 025990/0304 →
Second Lien Patent Security Agreement
Mar 21, 2011
From: GLOBAL TEL*LINK CORPORATION; DSI-ITI, LLC
To: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
Reel/Frame 025990/0257 →
Release of Patent Security Agreement
Jan 4, 2012
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: GLOBAL TEL*LINK CORPORATION; DSI-ITI, LLC; VALUE-ADDED COMMUNICATIONS, INC.; 3V TECHNOLOGIES INCORPORATED
Reel/Frame 027479/0431 →
Patent Security Agreement
Jan 5, 2012
From: DSI-ITI, LLC; GLOBAL TEL*LINK CORPORATION; VALUE-ADDED COMMUNICATIONS, INC.; 3V TECHNOLOGIES INCORPORATED
To: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
Reel/Frame 027489/0073 →